Joensuu, H. et al. 2014. Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). Acta Oncologica. 53, 2 (Feb. 2014), 186–194. DOI:https://doi.org/10.3109/0284186X.2013.820840.